References
C. H. Fiske and Y. Subbarow,Science,70, 381 (1929).
G. H. Hitchings, Dissertation, Harvard University (1933).
D. D. Woods,Brit. J. Exptl. Path.,21, 74 (1940).
P. Fildes,Lancet I, 955 (1940).
G. H. Hitchings, E. A. Falco and M. B. Sherwood,Science,102, 251 (1945).
E. A. Falco, G. H. Hitchings, P. B. Russell and H. Vander Werff,Nature,164, 107 (1949).
G. H. Hitchings, G. B. Elion, H. Vander Werff and E. A. Falco,J. Biol. Chem.,174, 765 (1948).
J. H. Burchenal, D. A. Karnofsky, E. M. Kingsley-Pillers, C. M. Southam, W. P. Laird Meyers, G. C. Escher, L. F. Craver, H. W. Dargeon and C. P. Rhoads,Cancer,4, 549 (1951).
G. H. Hitchings,Drug Intell. Clin. Pharn.,16, 843 (1982).
G. H. Hitchings and J. J. Burchall,Adv. Enzymol.,27, 417 (1965).
G. H. Hitchings and S. L. Smith,Adv. Enzyme Reg.,18, 349 (1980).
G. H. Hitchings and B. Roth, inEnzyme Inhibitors as Drugs, Ed. by M. Sandler, Baltimore University Park Press, pp. 263–280 (1980).
G. H. Hitchings, E. A. Falco, G. B. Elion, S. Singer, G. B. Waring, D. J. Hutchinson and J. H. BurchenalArch. Biochem. Biophys.,40, 479 (1952).
G. H. Hitchings, inDrugs, Parasites and Hosts, Ed. by L. G. Goodwin and R. H. Nimmo-Smith Boston, Little-Brown, pp. 196–210 (1962).
A. C. Y. Chang, J. H. Nunberg, R. J. Kaufman, H. A. Erlich, R. T. Schimke and S. N. Cohen,Nature,275, 617 (1978).
S. RichardsonAdv. Protein Chem. 34, 167 (1981).
D. A. Matthews, S. L. Smith, D. P. Baccanari, J. J. Burchall, S. J. Oatley and J. Kraut,Biochemistry 25, 4194 (1986).
J. Burchall, Wellcome Scientist Lecture (1983).
S. R. M. Bushby, inTrimethoprim-sulfamethoxazole, Microbiological, Pharmacological and Clinical Considerations, Ed. by M. Finland and E. H. Kass, pp. 10–30 (1973).
G. B. Elion, S. Singer and G. H. Hitchings,Antibiot. Chemother.,10, 556 (1960).
S. Farber et alN. Engl. J. Med.,238, 787 (1948).
B. Roth, E. Bliss, and C. R. Beddell, inMolecular Aspects of Anti-Cancer Drug Action, Ed. by S. Neidle and M. J. Waring, London, Macmillan, pp. 363–393 (1983).
D. A. Matthews, J. T. Bolin, J. M. Burridge, D. J. Filman, K. W. Volz, B. T. Kaufman, C. R. Beddell, J. N. Champness, D. K. Stammers and J. Kraut,J. Biol. Chem.,260, 381 (1985).
J. E. Villafranca, E. H. Howell, D. H. Voet, M. S. Strobel, R. C. Ogden, J. N. Abelson and J. Kraut,Science,222, 782 (1983).
J. J. McGuire and J. K. Coward, inFolates and Pterins, Vol 1, Ed. by R. L. Blakley and S. J. Benkovic, New York, Wiley, pp. 135–190 (1984).
C. J. Allegra, J. C. Drake, J. Jolivet and B. A. Chabner, inProceedings of the Second Workshop on Folyl and Antifolyl Polyglutamates, Ed. by I. D. Goldman, New York, Praeger, pp. 348–359 (1985).
C. R. Beddell, inX-ray Crystallography and Drug Action, Ed. by A. S. Horn and C. J. DeRanter, Oxford, Oxford Univ. Press, 169–193 (1984).
L. F. Kuyper, B. Roth, D. P. Baccanari, R. Ferone, C. R. Beddell, J. N. Champness, D. K. Stammers, J. G. Dann, F. E. Norrington and D. J. Baker,J. Med. Chem.,28, 303 (1985).
J. H. Chan, L. F. Kuyper and B. Roth,189th Am. Chem. Soc. Meeting Abstracts, MEDI 87 (1985).
J. T. Lin and J. R. Bertino,J. Clin. Oncol.,5, 2032 (1987).
C. J. Allegra, B. A. Chabner, C. U. Tuazon, D. Ogata-Arakaki, B. Baird, J. C. Drake, J. T. Simmons, E. E. Lack, J. H. Shelhamer, F. Balis, R. Walker, J. A. Kovacs, H. C. Lane and H. Masur,N. Engl. J. Med.,317, 978 (1987).
F. Aruajo, D. R. Guptill and J. S. Remington,J. Infect. Dis.,156, 828 (1987).
D. J. Fernandes, J. R. Bertino and J. B. Hynes,Cancer Res.,43, 1117 (1983).
G. H. Hitchings, inDiscoveries, Ed. by A. Burgen, Cambridge, Cambridge University Press, in press.
G. H. Hitchings,Cancer Res.,29, 1895 (1969).
Author information
Authors and Affiliations
Additional information
The Nobel Foundation 1989.
Rights and permissions
About this article
Cite this article
Hitchings, G.H. Selective inhibitors of dihydrofolate reductase. In Vitro Cell Dev Biol 25, 303–310 (1989). https://doi.org/10.1007/BF02624591
Issue Date:
DOI: https://doi.org/10.1007/BF02624591